Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Specialised early intervention teams for first episode psychosis

Puntis S. et al, (2019), Cochrane Database of Systematic Reviews, 2019

Pro-cognitive effect of a prebiotic in psychosis: A double blind placebo controlled cross-over study.

Kao AC-C. et al, (2019), Schizophr Res

The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data.

Al-Diwani A. et al, (2019), Lancet Psychiatry, 6, 235 - 246

Prebiotic reduction of brain histone deacetylase (HDAC) activity and olanzapine-mediated weight gain in rats, are acetate independent.

Kao AC-C. et al, (2019), Neuropharmacology

Neuroimmunology 2017: making progress over 20 years

(2018), Lancet Psychiatry

Bullying Victimisation and Risk of Psychotic Phenomena

Broome M. et al, (2018), EARLY INTERVENTION IN PSYCHIATRY, 12, 83 - 83

The effect of a youth mental health service model on access to secondary mental healthcare for young people aged 14-25 years.

Maxwell S. et al, (2018), BJPsych Bull, 1 - 5

Discharge pathways and relapse following treatment from early intervention in psychosis services.

Puntis S. et al, (2018), BJPsych Open, 4, 368 - 374

Mental health: a global focus 2018.

Tomlinson A. et al, (2018), Lancet Psychiatry, 5

Time for a change of practice: the real-world value of testing for neuronal autoantibodies in acute first-episode psychosis.

Pollak TA. and Lennox BR., (2018), BJPsych Open, 4, 262 - 264

Treating Sleep Problems in Young People at Ultra-High Risk of Psychosis: A Feasibility Case Series.

Bradley J. et al, (2018), Behav Cogn Psychother, 46, 276 - 291

38. DO NMDAR ANTIBODIES CAUSE SCHIZOPHRENIA?

Lennox B., (2018), Schizophrenia Bulletin, 44, S60 - S60

38. DO NMDAR ANTIBODIES CAUSE SCHIZOPHRENIA?

Lennox B., (2018), Schizophrenia bulletin, 44, S60 - S60

38.3 ONGOING GERMINAL CENTRE REACTIONS CONTRIBUTE TO N-METHYL-D-ASPARTATE RECEPTOR (NMDAR) ANTIBODY PRODUCTION IN NMDAR-ANTIBODY ENCEPHALITIS.

Makuch M. et al, (2018), Schizophrenia bulletin, 44, S61 - S61

DO NMDAR ANTIBODIES CAUSE SCHIZOPHRENIA?

Lennox B., (2018), SCHIZOPHRENIA BULLETIN, 44, S60 - S60

F88. MANIPULATION OF THE GUT MICROBIOTA WITH A PREBIOTIC IN SCHIZOPHRENIA: A DOUBLE-BLINDED RANDOMIZED PLACEBO-CONTROLLED CROSS-OVER STUDY

Kao A. et al, (2018), Schizophrenia Bulletin, 44, S254 - S254

F88. MANIPULATION OF THE GUT MICROBIOTA WITH A PREBIOTIC IN SCHIZOPHRENIA: A DOUBLE-BLINDED RANDOMIZED PLACEBO-CONTROLLED CROSS-OVER STUDY

Kao A. et al, (2018), Schizophrenia bulletin, 44, S254 - S254

MANIPULATION OF THE GUT MICROBIOTA WITH A PREBIOTIC IN SCHIZOPHRENIA: A DOUBLE-BLINDED RANDOMIZED PLACEBOCONTROLLED CROSS-OVER STUDY

Kao A. et al, (2018), SCHIZOPHRENIA BULLETIN, 44, S254 - S254

ONGOING GERMINAL CENTRE REACTIONS CONTRIBUTE TO N-METHYL-D-ASPARTATE RECEPTOR (NMDAR) ANTIBODY PRODUCTION IN NMDAR-ANTIBODY ENCEPHALITIS

Makuch M. et al, (2018), SCHIZOPHRENIA BULLETIN, 44, S61 - S61

Influence of prebiotic intake on olanzapine-mediated weight gain, central receptors, peripheral biomarkers, and gut microbiota

Kaon A. et al, (2018), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 28, S14 - S15

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?